drugset / Trial / NCT02398097

Conventional Vaccine and Intradermal Vaccine Among HIV-infected Young Subjects

NCT02398097

Phase 4 Completed 88 enrolled Korea University Guro Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

Several studies have shown poor immune response to conventional influenza vaccines in HIV-infected individuals. This study was conducted expecting the more potent immunogenicity of intradermal vaccine compared with conventional intramuscular vaccine in HIV-infected adults.

Timeline

Start
2011-11
Primary completion
2011-12
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Agripal Unknown Intramuscular
Comparator IDflu Vaccine 9 ug Other
Comparator IDflu Vaccine 15 ug Other

Indications